Ultravist 240

Ultravist 240 is a medicine authorised by Swissmedic under authorisation number 46969. The authorisation holder is Bayer (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 May 1986 and the authorisation is valid without a time limit. ATC code V08AB05 places the medicine in the group Contrast media.

Dispensing category B
Authorisation number 46969
ATC V08AB05
Synthetic medicines

Authorisation data
Authorisation number	46969
Name	Ultravist 240
Full name	Ultravist 240, Injektions-/Infusionslösung
Authorisation holder	Bayer (Schweiz) AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	V08AB05
First authorisation	06 May 1986
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Ultravist 240, Injektions-/Infusionslösung	B	06 May 1986
2	Ultravist 300, Injektions-/Infusionslösung	B	06 May 1986
3	Ultravist 370, Injektions-/Infusionslösung	B	06 May 1986
4	Ultravist 150, Injektions-/Infusionslösung	B	26 March 1991

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
4	1 x 50	ml	V08AB05	14.01.0.	B
5	1 x 10	ml	V08AB05	14.01.0.	B
6	1 x 20	ml	V08AB05	14.01.0.	B
7	10 x 50	ml	V08AB05	14.01.0.	B
8	10 x 100	ml	V08AB05	14.01.0.	B
9	1 x 50	ml	V08AB05	14.01.0.	B
10	1 x 100	ml	V08AB05	14.01.0.	B
11	1 x 200	ml	V08AB05	14.01.0.	B
12	10 x 200	ml	V08AB05	14.01.0.	B
13	8 x 500	ml	V08AB05	14.01.0.	B
18	10 x 50	ml	V08AB05	14.01.0.	B
19	10 x 100	ml	V08AB05	14.01.0.	B
20	1 x 200	ml	V08AB05	14.01.0.	B
21	1 x 30	ml	V08AB05	14.01.0.	B
22	1 x 50	ml	V08AB05	14.01.0.	B
23	1 x 100	ml	V08AB05	14.01.0.	B
24	10 x 200	ml	V08AB05	14.01.0.	B
25	8 x 500	ml	V08AB05	14.01.0.	B
2	1 x 50	ml	V08AB05	14.01.0.	B
3	1 x 200	ml	V08AB05	14.01.0.	B

Scroll the table sideways

Other medicines from this authorisation holder

Adempas 0.5 mgAuthorisation number 62903 · ATC C02KX05B Adempas junior 0.15 mg/mlAuthorisation number 69929 · ATC C02KX05B AleveAuthorisation number 53810 · ATC M01AE02D Alka-SeltzerAuthorisation number 8671 · ATC N02BA01D Ambelvist 0.1 mmol/ mlAuthorisation number 70405 · ATC V08CA13B Ambelvist 0.1 mmol/ mlAuthorisation number 70441 · ATC V08CA13B Ambelvist 0.1 mmol/ nlAuthorisation number 70440 · ATC V08CA13B AngeliqAuthorisation number 56275 · ATC G03FA17B

Frequently asked questions

Is Ultravist 240 authorised in Switzerland?

Yes. Ultravist 240 is authorised by Swissmedic under authorisation number 46969, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Ultravist 240 have?

Ultravist 240 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Ultravist 240?

The authorisation holder is Bayer (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.